That's the first thing that is going to happen and that will likely be a signal to Wall Street that they are missing the point. These companies are extremely healthy in terms of their product development. The small-cap companies are very much undervalued right now and it's going to be somebody's opportunity.

Carl Feldbaum

Related Quotes

a festive, colorful group ... (that) doesn't have a clue about what the biotechnology industry does.

— Carl Feldbaum

It is unclear how this occurred, but we must find out.

— Carl Feldbaum

The irony is that this industry took a hit at a time when nearly 300 biotech drugs and vaccines are in human clinical trials. The pipelines have never been fuller. I think it'll take investors a little more time to recognize that before small-cap stocks will come back.

— Carl Feldbaum

The irony is that this industry took a hit at a time when nearly 300 biotech drugs and vaccines are in human clinical trials, ... The pipelines have never been fuller. I think it'll take investors a little more time to recognize that before small-cap stocks will come back.

— Carl Feldbaum

What's the harm of a little mystification? It sure beats boring statistical analyses.